Trials / Unknown
UnknownNCT01026350
Safety and Efficacy of Oral Colostrum Derived Anti Influenza Antibodies in Healthy Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Hadassah Medical Organization · Academic / Other
- Sex
- Male
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Administration of colostrum enriched with anti-Flu antibodies may alter host's response to the flu virus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | colostrum enriched with anti flu antibodies | each volunteer will receive six 1.2 g oral tablets (equivalent to 600 mg of bovine colostrum powder each) once a day for two weeks. |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-01-01
- First posted
- 2009-12-04
- Last updated
- 2009-12-04
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01026350. Inclusion in this directory is not an endorsement.